Loading...
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Since the clear demonstration of lysophosphatidic acid (LPA)’s pathological roles in cancer in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were published. Through these studies, LPA was established as a target for cancer. Although LPA-related inhibitors entered clini...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826372/ https://ncbi.nlm.nih.gov/pubmed/31658655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101523 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|